ResearcherNorth Sichuan Medical UniversityNo recent work listed

Chen Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3646-1813; OpenAlex author ID A5100418337. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper

Papers 2

Reversing immune evasion using a DNA nano-orchestrator for pancreatic cancer immunotherapy. Co-author DOI 10.1016/j.actbio.2023.05.001 ↗
Molecular Imaging with MRI: Potential Application in Pancreatic Cancer. Co-author DOI 10.1155/2015/624074 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Cai Zhang · 1 shared paper, 2023 · strength 0.16
- Paper Reversing immune evasion using a DNA nano-orchestrator for pancreatic cancer immunotherapy. DOI 10.1016/j.actbio.2023.05.001 ↗
Xinyi Jiang · 1 shared paper, 2023 · strength 0.16
- Paper Reversing immune evasion using a DNA nano-orchestrator for pancreatic cancer immunotherapy. DOI 10.1016/j.actbio.2023.05.001 ↗
Xiaotian Zhao · 1 shared paper, 2023 · strength 0.16
- Paper Reversing immune evasion using a DNA nano-orchestrator for pancreatic cancer immunotherapy. DOI 10.1016/j.actbio.2023.05.001 ↗
Xiao Ming Zhang · 1 shared paper, 2015 · strength 0.06
- Paper Molecular Imaging with MRI: Potential Application in Pancreatic Cancer. DOI 10.1155/2015/624074 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.